[1]
von Bardeleben, R.S., Khan, M.S., Geyer, M., Friede, T., Butler, J., Diek, M., Heinrich, J., Placzek, M., Ferrari, R., Abraham, W.T., Alfieri, O., Auricchio, A., Bayes-Genis, A., Cleland, J.G., Filippatos, G., Gustafsson, F., Haverkamp, W., Kelm, M., Kuck, K.-H., Landmesser, U., Maggioni, A.P., Metra, M., Ninios, V., Petrie, M.C., Rassaf, T., Ruschitzka, F., Schäfer, U., Schulze, P.C., Spargias, K., Vahanian, A., Zamorano, J.L., Zeiher, A., Karakas, M., Koehler, F., Lainscak, M., Öner, A., Mezilis, N., Theofilogiannakos, E.K., Ninios, I., Chrissoheris, M., Kourkoveli, P., Papadopoulos, K., Smolka, G., Wojakowski, W., Reczuch, K., Pinto, F.J., Wiewiórka, Łukasz, Kalarus, Z., Adamo, M., Santiago-Vacas, E., Ruf, T.F., Gross, M., Tongers, J., Hasenfuß, G., Schillinger, W., Ponikowski, P. and Anker, S.D. 2024. Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR. Global Cardiology. 2, 2 (Jun. 2024). DOI:https://doi.org/10.4081/cardio.2024.40.